相关实验视频

Updated: Jun 4, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

基于端粒酶的疫苗:在癌症免疫治疗中是一个有希望的前沿

Sogand Vahidi¹, Arefeh Zabeti Touchaei²

¹Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. so.vahidii@gmail.com.

Cancer cell international

|December 20, 2024

概括

针对人类端粒酶逆转录酶 (hTERT) 的基于端粒酶的疫苗在癌症免疫治疗方面表现有前途. 虽然DNA和类疫苗已经证明了临床有效性,但需要进一步的研究来确保持久的抗瘤免疫力.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗开发疫苗开发

背景情况:

端粒酶对于端粒维护和细胞不朽是必不可少的.
在大多数癌症中,端粒酶的过度表达,特别是人类端粒酶逆转录酶 (hTERT),使其成为一种有吸引力的免疫治疗点.

研究的目的:

审查用于癌症治疗的基于端粒酶的疫苗的开发和应用.
评估DNA和类疫苗的方法,包括它们的免疫性和临床疗效.

主要方法:

对基于端粒酶的疫苗的临床前和临床数据的审查.
分析疫苗设计的进展,包括多种和辅助剂.
讨论作用机制和免疫反应诱导.

主要成果:

DNA 疫苗显示出有前途的免疫性.
类疫苗 (例如UV1,UCPVax,Vx-001) 在特定的癌症类型中已经证明了临床疗效.
通过改进的疫苗设计观察到增强的免疫反应.

结论:

基于端粒酶的疫苗代表了癌症免疫治疗的有希望的策略.
在实现一致和持久的抗瘤免疫反应方面,仍然存在挑战.
进一步的研究对于优化疫苗疗效和临床应用至关重要.

关键词:

癌症免疫疗法癌症免疫疗法这种疫苗是DNA疫苗.类疫苗类疫苗泰隆玛酶的使用方法赫特特是个很好的球员.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Replicative Cell Senescence

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Telomeres and Telomerase

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...